Apimeds Pharmaceuticals US, Inc. (APUS)
NYSEAMERICAN: APUS · Real-Time Price · USD
1.180
-0.060 (-4.84%)
Feb 24, 2026, 9:30 AM EST - Market open
APUS Market Cap
APUS has a market cap or net worth of $14.84 million as of February 24, 2026.
Market Cap
14.84M
Enterprise Value
n/a
1-Year Change
n/a
Ranking
Category
Stock Price
$1.18
Market Cap Chart
Since the IPO on December 9, 2025, APUS's market cap has decreased from $26.79M to $14.84M, a decrease of -44.60%. That is a compound annual growth rate of -94.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 17.48M | -15.26% |
| Dec 31, 2025 | 20.62M | -23.00% |
| Dec 9, 2025 | 26.79M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zhengye Biotechnology Holding | 41.70M |
| Rockwell Medical | 37.53M |
| Talphera | 36.20M |
| BioXcel Therapeutics | 34.34M |
| SCYNEXIS | 32.90M |
| TherapeuticsMD | 26.62M |
| Aytu BioPharma | 24.69M |
| Caring Brands | 12.09M |